ROHIT SRIVASTAVA to Cell Line, Tumor
This is a "connection" page, showing publications ROHIT SRIVASTAVA has written about Cell Line, Tumor.
Connection Strength
0.181
-
Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy. Commun Biol. 2020 06 05; 3(1):284.
Score: 0.096
-
Stimuli Responsive Molecular Exchange of Structure Directing Agents on Gold Nanobipyramids: Cancer Cell Detection and Synergistic Therapeutics. ACS Appl Bio Mater. 2024 07 15; 7(7):4542-4552.
Score: 0.032
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.028
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
Score: 0.025